- Home
- / NKGen Biotech
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
NKGen Biotech financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0.3
2024-10-29
Market Capitalization
$11 M
2024-10-29
CreditSafe Score
?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|
| General and administrative expense | 2.2M | 2.4M | 14.1M | 16.3M |
| Operating expense total | 2.2M | 2.4M | 29.7M | 27.0M |
| EBIT | (2.5M) | (2.7M) | (29.7M) | (27.0M) |
| Interest income | 41.2K | 2.4M | ||
| Interest expense | 745.0K | |||
| Pre tax profit | 5.0M | (82.9M) | ||
| Income tax expense | 438.4K | 7.0K | 53.0K | |
| Net Income | (990.6K) | 4.5M | (83.0M) | (44.3M) |
| EPS | (0.1) | 0.4 | (5.4) | (1.5) |